Release Date: 27/07/22 08:21 Summary: Quarterly Activities/Appendix 5B Cash Flow Report Price Sensitive: Yes Download Document 1.27MB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status